able
Age Group_Uncategorized
Age Group_Uncategorized
aim
along
approaches
automatic-update
B01=Ernest Giralt
B01=Mark Peczuh
B01=Xavier Salvatella
Category1=Non-Fiction
Category=PN
Category=PSB
Category=PSBC
Category=PSE
chance
complementation
COP=United States
Delivery_Delivery within 10-20 working days
design
development
drug
eq_bestseller
eq_isMigrated=2
eq_nobargain
eq_non-fiction
eq_science
extended
functionality
Language_English
large
molecular
new
PA=Available
patches
perspective
Price_€100 and above
protein
PS=Active
rational
recognition
softlaunch
strategy emphasizes
successful
surface
therapeutics
Product details
- ISBN 9780470059050
- Weight: 776g
- Dimensions: 175 x 252mm
- Publication Date: 12 Nov 2010
- Publisher: John Wiley & Sons Inc
- Publication City/Country: US
- Product Form: Hardback
- Language: English
Secure
checkout
Fast Shipping
Easy returns
A new perspective on the design of molecular therapeutics is emerging. This new strategy emphasizes the rational complementation of functionality along extended patches of a protein surface with the aim of inhibiting protein/protein interactions. The successful development of compounds able to inhibit these interactions offers a unique chance to selectively intervene in a large number of key cellular processes related to human disease.
Protein Surface Recognition presents a detailed treatment of this strategy, with topics including:
- an extended survey of protein-protein interactions that are key players in human disease and biology and the potential for therapeutics derived from this new perspective
- the fundamental physical issues that surround protein-protein interactions that must be considered when designing ligands for protein surfaces
- examples of protein surface-small molecule interactions, including treatments of protein-natural product interactions, protein-interface peptides, and rational approaches to protein surface recognition from model to biological systems
- a survey of techniques that will be integral to the discovery of new small molecule protein surface binders, from high throughput synthesis and screening techniques to in silico and in vitro methods for the discovery of novel protein ligands.
Protein Surface Recognition provides an intellectual “tool-kit” for investigators in medicinal and bioorganic chemistry looking to exploit this emerging paradigm in drug discovery.
ERNEST GIRALT, Department of Organic Chemistry, University of Barcelona and Institute for Research in Biomedicine, Barcelona, Spain
MARK PECZUH, Department of Chemistry, University of Connecticut, USA
XAVIER SALVATELLA, ICREA and Institute for Research in Biomedicine, Barcelona, Spain
